SAM SIGNED

Project "SAM" data sheet

The following table provides information about the project.

 Partnership

Take a look of project's partnership.

Map

 Project objective

Silk Aquamelts to Market (SAM) will catalyse the process of bringing Spintex Engineering’s silk aquamelts, as high-performance artificially spun fibres, to the medical market. SAM aims to fully commercialise our bespoke silks, for novel healthcare solutions. Objective 1 starts with a market analysis of medical biotextiles and their patent landscape. A dedicated research analyst will identify networking, commercial and regulatory opportunities/challenges for our company’s novel and unmatched fibres. Sharing the results of this work, the market analysis will provide a detailed feasibility study for silk aquamelts in the biotextiles sector, assisting further developments from FLIPT members and their own roadmapping work which is currently textile focused. By focusing on healthcare SAM will target a market with attractive profit margins, and demonstrate the viability of the aquamelt pathway in a heavily regulated industry. Objective 2 will tackle this regulatory compliance and certification in Good Manufacturing Practice (GMP), and ISO 10993 & 13485 for our silk aquamelts. By training key personnel in compliance with ISO standards and GMP, audit certification with EU notified bodies and receipt of CE marks will be achieved and individuals upskilled. We will demonstrate silk aquamelts’ utility and safety and add value to FLIPT, by expanding the opportunities available for other aquamelt materials and assisting their route to market. Furthermore, contact with investors, customers and at conferences, will establish the aquamelt pathway as the future of EU fibre production. This will directly benefit the uptake of future aquamelt developments from the FLIPT project and help several key work packages and tasks.